Abstract:The myb gene family consists of three members, named A, B and c-myb which encode nuclear proteins that function as transcriptional transactivators. Proteins encoded by these three genes exhibit a tripartate structure with an N-terminal DNA-binding domain, a central transactivation domain and a C-terminal regulatory domain. These proteins exhibit highest homology in their DNA binding domains and appear to bind DNA with overlapping sequence specificities. Transactivation by myb gene family varies considerably depending on cell type and promoter context suggesting a dependence on interaction with other cell type specific co-factors. While the C-terminal domains of A-Myb and c-Myb proteins exert a negative regulatory effect on their transcriptional transactivation function, the C-terminal domain of B-Myb appears to function as a positive regulator of this activity. One or more of these proteins interact with other transcription factors such as Ets-2, CEBP and NF-M. In addition, expression of these genes is cell cycle-regulated and inhibition of their expression with anti-sense oligonucleotides has been found to affect cell cycle-progression, cell division and/or differentiation. Members of the myb gene family exhibit different temporal and spatial expression patterns suggesting a distinctive function for each of these genes. Gene knockout experiments show that these genes play an essential role in development. Loss of c-myb function results in embryonic lethality due to failure of fetal hepatic hematopoiesis. A-myb null mutant mice, on the other hand are viable but exhibit growth abnormalities, and defects in spermatogenesis and female breast development. While the role of c-myb in oncogenesis is well established, future experiments are likely to provide further clues regarding the role of A-myb and B-myb in tumorigenesis.

C-Myb Regulates Cell Cycle-Dependent Expression of Erbin: an Implication for a Novel Function of Erbin.

Eb1 Acetylation By P300/Cbp-Associated Factor (Pcaf) Ensures Accurate Kinetochore-Microtubule Interactions In Mitosis

Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR.

Erbin Inhibits Transforming Growth Factor Β Signaling Through a Novel Smad-Interacting Domain

Role of Erbin in Erbb2-Dependent Breast Tumor Growth

ErbB2/HER2 governs CDK4 inhibitor sensitivity and timing and irreversibility of G1/S transition by altering c-Myc and cyclin D function

EB1 acts as an oncogene via activating beta-catenin/TCF pathway to promote cellular growth and inhibit apoptosis

c-Myb is a novel regulator of Bcl-xL in the CD4+ and CD8+ double positive stage of T cell development (85.2)

Genome-wide binding analysis unveils critical implication of B-Myb-mediated transactivation in cancers

Ubp-M Serine 552 Phosphorylation By Cyclin-Dependent Kinase 1 Regulates Cell Cycle Progression

C/EBPβ Is a Transcriptional Regulator of Wee1 at the G2/M Phase of the Cell Cycle

Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors

B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells

The myb gene family in cell growth, differentiation and apoptosis

Histone demethylase Kdm4b functions as a co-factor of C|[sol]|EBP|[beta]| to promote mitotic clonal expansion during differentiation of 3T3-L1 preadipocytes

E3 Ubiquitin Ligase RLIM Negatively Regulates c-Myc Transcriptional Activity and Restrains Cell Proliferation

Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells

Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer

Histone demethylase Kdm4b functions as a co-factor of C/EBP β to promote mitotic clonal expansion during differentiation of 3T3-L1 preadipocytes

c-myb is involved in CML progression and is a therapeutic target in the zebrafish CML model

CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway